Additional Study Information: The purpose of this study is to determine whether treatment with anticoagulation medications incombination with the EkoSonicTM Endovascular device with a dose of a clot-dissolving drug(thrombolytic) can reduce the risk of death and other serious problems when compared toanticoagulation medication alone. Other measurements will be taken to observe your overall health and quality of life for one year after treatment.